OSR Health Adds $15M Convertible Note Option to VXM01 License Settlement
OSRHW has more than doubled off its 52-week low of $0.005.
Summary
OSR Health amended its VXM01 license agreement to allow up to $15M of its stock put option to be settled instead through convertible notes priced at $2.00-$5.00 per share, a response to the Nasdaq delisting determination.
Key Events · Financing and Capital Events · OSRHW
-
Convertible Note Option Added
Amendment No. 1 adds Section 6.10, letting OSR Health convert up to $15,000,000 of its unexercised Equity Option into Convertible Notes purchased by BCME or a third party at par.
-
Conversion Prices Set at $2.00-$5.00
Four tranches of $3,750,000 each convert at approximately $2.00, $3.00, $4.00 and $5.00 per share, with no reset; these prices are far above the current $0.0113 stock price.
-
Closing Contingent on Purchaser Commitment
BCME must deliver a binding purchaser commitment with or before the Note Election Notice, and closing occurs no fewer than 20 business days after the notice; failure to close within 10 business days reinstates the Equity Option.
-
Nasdaq Delisting Cited as Trigger
The parties acknowledge the August 19, 2026 Nasdaq delisting determination as a material subsequent development affecting settlement of the Equity Option.
Analysis · OSRHW · Industrial Applications And Services
OSR Health and BCM Europe amended the VXM01 license agreement to let OSR Health swap its $15M stock put option for convertible notes. The notes convert at $2.00-$5.00 per share, far above the current $0.0113 stock price, so the conversion feature is deeply out of the money and the notes function more like a fixed-price financing backstop than near-term dilution. The amendment was prompted by Nasdaq's August 19, 2026 delisting determination, which the parties call a material development affecting settlement. The structure gives OSR Health a fallback if the equity option cannot be exercised, but the $15M is contingent on BCME delivering a purchaser and closing within the specified window; if it fails, the equity option is reinstated.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 36.6% of the 978 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OSRHW was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.01 to $0.10. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.